Monday, August 10, 2026

🧠 CALL FOR ABSTRACTS | NEURO CARE-2027 🔬

Are you working on groundbreaking research, innovative clinical approaches, or emerging discoveries in Neurology and Neuroscience?

Share Your Research. Inspire New Ideas. Shape the Future of Neuroscience.

The 2nd Edition of the International Conference on Neurology and Neuroscience (Neuro Care-2027) invites researchers, neurologists, neuroscientists, clinicians, healthcare professionals, academics, and industry experts to submit their latest research and scientific findings.


📅 March 22–24, 2027
📍 Singapore & Online
🌐 Hybrid Conference

🔬 Key Scientific Areas Include:
▸ Clinical Neurology & Neurophysiology
▸ Neurological Diseases & Disorders
▸ Neuroimmunology & Neuroinflammation
▸ Neuroimaging & Diagnostic Techniques
▸ Neurosurgery & Surgical Advances
▸ Neurogenetics & Genomics
▸ Neuropsychology & Cognitive Neuroscience
▸ Aging & Neurodegeneration
▸ Neurological Rehabilitation & Neuroplasticity
▸ Neurotechnology, AI & Computational Neuroscience
▸ Clinical Trials & Case Reports
▸ Recent Breakthroughs & Future Directions in Neurology

🎤 Why Submit Your Abstract?
✔ Present your research to an international scientific audience
✔ Gain valuable exposure for your work
✔ Connect with researchers and experts from around the world
✔ Opportunity for oral or poster presentation
✔ Accepted abstracts will be included in the conference proceedings book with DOI assignment

📢 Encore abstracts are also welcome!

📝 Submit Your Abstract Today:
https://neurocareconference.com/abstract-submission

🌐 Conference Website:
https://neurocareconference.com/

🚀 Your research could be the next step toward advancing neurological science. Submit your abstract and be part of the global neuroscience community!

#NeuroCare2027 #CallForAbstracts #AbstractSubmission #Neurology #Neuroscience #NeurologyConference #NeuroscienceConference #ClinicalNeurology #Neurotechnology #Neuroimaging #Neurorehabilitation #Neurodegeneration #Neurogenetics #AIinNeuroscience #SingaporeConference

No comments:

Post a Comment